कोशिश गोल्ड - मुक्त
Duplantis soars to impossible heights
Mint Hyderabad
|May 10, 2025
Swedish-American pole-vaulter Mondo Duplantis breaks multiple records, cementing his status as an all-time great
In 2024, there were athletes, and then there was Mondo Duplantis. To describe that season, words are hard to come by, and Duplantis himself mutters things like "weird" and "surreal".
But if there's one word that, casting aside superlatives, captures the essence of the 25-year-old Swedish-American pole-vaulter's year—15 wins in 15 competitions, world champion, European Champion, Olympic champion, and three-time world record breaker—it's this: impossible.
Any athlete operating in the top tier would like to believe that they are chasing the impossible, that they are on a quest to turn dreams into reality.
Once in a generation, that really happens. Duplantis belongs, with consummate ease, in the same sphere as Usain Bolt, Michael Phelps, Simone Biles and Eliud Kipchoge. So far ahead of the rest that during the Paris Olympics, with the pole-vault competition done—in fact all events for the day were over—and the gold in his pocket, Duplantis, who still had a couple of jumps left, if he wished to take them, decided to go for the world record.
More than 77,000 people inside the sweltering, heaving Stade De France roared and chanted, "Mondo, Mondo, Mondo". Even his opponents, the entire pool of finalists in the men's pole vault, stood on the sidelines egging him on. He had won the Olympic gold with a 6.0m jump, so he first loosened up with a 6.10m jump to set the Olympic record. Then he raised the bar to 6.25m, jack-knifed and soared over it like only he can, accompanied by a deafening wall of sound, to break the world record for the ninth time.
Duplantis had become the first man to break the pole-vault world record in an Olympic final and the first to win back-to-back Olympic golds in the event since US's Bob Richards in 1952 and 1956.
यह कहानी Mint Hyderabad के May 10, 2025 संस्करण से ली गई है।
हजारों चुनिंदा प्रीमियम कहानियों और 10,000 से अधिक पत्रिकाओं और समाचार पत्रों तक पहुंचने के लिए मैगज़्टर गोल्ड की सदस्यता लें।
क्या आप पहले से ही ग्राहक हैं? साइन इन करें
Mint Hyderabad से और कहानियाँ
Mint Hyderabad
Nvidia, Eli Lilly to invest $1 bn in AI lab
Nvidia Corp. plans to invest $1 billion over five years in a new laboratory with Eli Lilly & Co., aiming to speed up the use of artificial intelligence (AI) in the pharmaceutical industry.
1 min
January 13, 2026
Mint Hyderabad
Shadowfax IPO to open next week
Logistics services provider Shadowfax is set to launch its ₹1,900-crore initial public offering (IPO) next week, targeting a valuation of ₹7,400 crore, people familiar with the matter said on Monday.
1 min
January 13, 2026
Mint Hyderabad
The US climate cop-out should galvanize others
America's withdrawal from the global battle against climate change is a signal for the rest of the world to unite for the greater good. The cause is vital, not the participation of the US
2 mins
January 13, 2026
Mint Hyderabad
Toyota pushes for fuel norm clarity
The government should soon come out with the final notification for the next phase of India’s Corporate Average Fuel Efficiency standards so that the industry can prepare accordingly, according to a senior Toyota Kirloskar Motor executive.
1 min
January 13, 2026
Mint Hyderabad
Food effect lifts Dec CPI inflation
India's retail inflation rose for the second successive month in December, data released by the statistics ministry on Monday showed, driven by a moderation in negative food inflation and an uptick in core inflation.
1 min
January 13, 2026
Mint Hyderabad
Commissions trump advice in wealth management biz
surge on rising affluence, strong economic growth, higher foreign direct investments, and the growth of the startup ecosystem.
2 mins
January 13, 2026
Mint Hyderabad
The Chinese company taking on the world's memory-chip giants
As AI demand drives prices up, CXMT beats Washington's curbs to vie with Micron and South Korean leaders
4 mins
January 13, 2026
Mint Hyderabad
HC lifts ban on Zydus cancer biosimilar till patent expiry
In a relief for Zydus Lifesciences, a division bench of the Delhi High Court on Monday allowed the drugmaker to sell and market its biosimilar of the anticancer drug nivolumab in India, citing public interest.
2 mins
January 13, 2026
Mint Hyderabad
Fix GST on capital goods to revive private investment
India faces a paradox today.
3 mins
January 13, 2026
Mint Hyderabad
Feeling tired? It could be too many messages
The cumulative stress of constant notifications is leaving many emotionally burnt out. Tackling it requires small, sustainable changes
4 mins
January 13, 2026
Listen
Translate
Change font size
